Tuesday, March 31, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Is Europe a Leading Indicator for COVID-19?

Daily Remedy by Daily Remedy
November 28, 2021
in Trends
0
Is Europe a Leading Indicator for COVID-19?

Data is many things. But above all, it is counterintuitive.

The more we add to it, the more complex it becomes. The more complex it becomes, the greater the probability of error.

Yet we cannot curb this tendency of adding more variables to data – almost like we are compelled to believe the more variables we study in a given data set, the more accurate it becomes.

Like most counterintuitive concepts in healthcare, our intuition fails us, leading down a road of false equivalencies and misplaced attributions.

This seems to be where we are at currently, heading into the second pandemic winter and anticipating another COVID-19 surge in cases. After all, we see cases rising all across Europe and a new variant, Omicron, seems to have captured the media’s attention for the moment.

Germany, with 68% percent of the population fully vaccinated and known for adhering steadfastly to mask mandates and social distancing protocols, is experiencing its highest peak in COVID-19 cases since the pandemic started.

Norway, with 86% percent of the population 18 and older vaccinated, is also bracing for an uptick in COVID-19 cases. “Based on an overall assessment, we believe it is likely that we will get a wave [of COVID-19 infections] during the winter,” said Miss Camilla Stoltenberg, head of the Norwegian Institute of Public Health.

Throughout Europe, from the United Kingdom to Germany, COVID-19 cases are rising, and policy experts across the world are bracing for the worst – particularly in the United States.

Growing outbreaks in the Midwest and Northeast are responsible for the recent increase in COVID-19 cases in the United States, which is coming after weeks of regional surges in the Mountain West where some hospitals are still grappling with hospital capacity constraints.

And of course, whenever COVID-19 cases surge, people look for things to blame. Some believe the rising cases in highly vaccinated countries are proof the vaccines are ineffective. Some are even blaming the type of vaccine.

The CEO of AstraZeneca, Pascal Soriot, blames the recent surge on the mRNA vaccines produced by Moderna and Pfizer-BioNTech. Soriot said, “it’s really interesting when you look at the UK. There was a big peak of infections but not so many hospitalizations relative to Europe. In the UK [the Oxford/AstraZeneca] vaccine was used to vaccinate older people whereas in [other parts of] Europe people thought initially [our] vaccine doesn’t work in older people.”

But blaming any one attribute or cause is nothing more than a logical failure, known among behavioral economists as attribution error. At the end of the day, we do not have a simple explanation for why COVID-19 cases are rising, as scary as that may appear. To blame any one thing – whether it is vaccines, mask mandates, or economic restrictions – overlooks the massive uncertainty in the data that we have yet to fully grasp.

There is more we do not know than know – even this late into the pandemic. But we continue to reach for convenient solutions.

In the United States, these solutions usually come in the form of political grandstanding over hot-button cultural issues. Those who support vaccinations will blame parts of the country with low vaccination rates, just like those who are against vaccinations will claim that vaccines are not effective.

The arguments are circular because the data remains inconclusive – so we apply value judgments to parts of the data that corroborate with what we already believe.

Ultimately, the rise in COVID-19 may be nothing more than broad endemic trend, like seasonal influenza. We may just have to learn to live with COVID-19. And cases along with new variants will appear with certain seasonality like influenza, or any other viral upper respiratory tract infection.

Vaccines will help those who are at risk and reduce the burden of treatment in hospital systems. But they will not stop people from getting infected.

Mask mandates and economic restrictions will reduce the transmission of viruses and prevent massive surges in COVID-19 that have overwhelmed hospitals in the past. But they will not stop the spread of the virus completely.

It is impossible to say how effective any one of these measures can be in isolation because their overall effect in curbing COVID-19 is fundamentally interdependent. Just like the rise in COVID-19 cases has no one cause or attributable factor.

Both the rise in cases and the mitigating treatment options operate within a broader system, influencing and impacting each other in a complex, coordinated dance that we do not yet understood.

As far as we know, the COVID-19 pandemic might have already transitioned into seasonal endemic infections, producing corona virus variants the same way other airborne viruses mutate. And we may not recognize this transition until months or years later.

We might not ever recognize it. We still do not have a full understanding of influenza after living with it for a century since the Spanish Flu. The only difference between influenza and COVID-19 is how we conceptualize it.

We accept seasonal rises in influenza and prepare for it accordingly. But when it comes to COVID-19, we cannot curb this tendency to analyze it ad nauseam, looking for something – really anything – to blame.

Europe may be a leading indicator, but the innumerable variables differentiating the United States from European countries begs the question of whether any perceived similarity is a real trend or just a convenient aberration in the numbers.

Instead of trying to predict it, to find blame out of it, we should learn to accept it. Accept that COVID-19 will be a seasonal endemic infection more severe than traditional influenza infections for at least another four to five years, at which time global herd immunity will have acclimated to the various COVID-19 variants.

And then we will live with endemic COVID variants like we live with annual influenza variants. We will try to predict the likely variants and formulate annual vaccines to maximize effectiveness – and over time we will be more right than wrong, just like we are with influenza vaccines.

Time, more than anything else, is the best indicator of how the pandemic will play out.

And eventually, we will learn to live with COVID-19 and accept it as part of our everyday lives, like we do all other airborne viruses swirling about.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Most employers are unknowingly steering their health plans toward higher costs and reduced control — until they understand how fiduciary missteps and anti-competitive contracts bleed their budgets dry. Katie Talento, a recognized health policy leader, reveals how shifting the network paradigm can save millions by emphasizing independent providers, direct contracting, and innovative tiering models.

Grounded in real-world case studies like Harris Rosen’s community-driven initiative, this episode dives deep into practical strategies to realign incentives—focusing on primary care, specialty care, and transparent vendor relationships. You'll discover how traditional carrier networks are often Trojan horses, locking employers into costly, opaque arrangements that undermine fiduciary duties. Katie breaks down simple yet powerful reforms: owning your data, eliminating conflicts of interest, and outlawing anti-competitive contract clauses.

We explore how a post-network framework—where patients are free to choose providers without restrictive network barriers—can massively reduce costs and improve health outcomes. You'll learn why independent, locally owned providers are vital to rebuilding trust, reducing unnecessary procedures, and reinvesting savings into the community. This conversation offers clarity on the unseen legal landmines employers face and actionable ways to craft health plans built on transparency, independence, and aligned incentives.

Perfect for HR pros, benefits advisors, physicians, and employer leaders committed to transforming healthcare from the ground up. If you’re tired of broken healthcare models draining your budget and frustrating your staff, this episode will empower you to take control by understanding and reshaping the very foundations of employer-sponsored health. Discover the blueprint for smarter, fairer, and more sustainable benefits.

Visit katytalento.com or allbetter.health to connect directly and explore how these innovations can work for your organization. Your path toward a healthier, more cost-effective future starts here.

Chapters

00:00 Introduction to Employer-Sponsored Health Plans
02:50 Understanding ERISA and Fiduciary Responsibilities
06:08 The Misalignment of Clinical and Financial Interests
08:54 Enforcement and Legal Implications for Employers
11:49 Redefining Networks: The Post-Network Framework
25:34 Navigating Healthcare Contracts and Cash Payments
27:31 Understanding Employer Health Plan Structures
28:04 The Role of Benefits Advisors in Health Plans
30:45 Governance and Data Ownership in Health Plans
37:05 Case Study: The Rosen Hotels' Health Model
41:33 Incentivizing Healthy Choices in Healthcare
47:22 Empowering Primary Care and Independent Providers
The Hidden Costs Employers Don’t See in Traditional Health Plans
YouTube Video xhks7YbmBoY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

by Daily Remedy
March 30, 2026
0

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Innocent Physician Still Punished

    Innocent Physician Still Punished

    0 shares
    Share 0 Tweet 0
  • Neuralink’s Healthcare Ambitions

    1 shares
    Share 0 Tweet 0
  • The Performance of Rest

    0 shares
    Share 0 Tweet 0
  • The Intimacy Economy

    0 shares
    Share 0 Tweet 0
  • The Price of Knowing You Might Live Longer

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy